再鼎医药盘前涨5.72% H股高涨超8.6% 下半年将开展肺癌第三阶段关键研究

金吾财讯
12 Jun

金吾财讯 | 再鼎医药(ZLAB)盘前股价拉升,暂报43.77美元,涨5.72%。今日港股医药板块涨势强劲,再鼎医药H股高收8.65%,报34.55港元。公司日前公布有关ZL-1310的正面数据,加上美国FDA已授出快速通道认证(Fast Track Designation),集团计划今年下半年开展第二类小细胞肺癌(2L SCLC)的第三阶段关键研究。美银发研指,基于以上临床进展,该行将集团...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10